254 related articles for article (PubMed ID: 35929142)
41. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
Wang S; Chen X; Qiao T
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
[TBL] [Abstract][Full Text] [Related]
42. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
43. Depletion of PCAT-1 in head and neck cancer cells inhibits tumor growth and induces apoptosis by modulating c-Myc-AKT1-p38 MAPK signalling pathways.
Sur S; Nakanishi H; Steele R; Ray RB
BMC Cancer; 2019 Apr; 19(1):354. PubMed ID: 30987615
[TBL] [Abstract][Full Text] [Related]
44. MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
Liu F; Zhao X; Qian Y; Zhang J; Zhang Y; Yin R
Biomed Pharmacother; 2017 Dec; 96():229-237. PubMed ID: 28987947
[TBL] [Abstract][Full Text] [Related]
45. FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma.
Liao Q; Yang J; Lu Z; Jiang Q; Gong Y; Liu L; Peng H; Wang Q; Zhang X; Liu Z
PeerJ; 2023; 11():e16493. PubMed ID: 38025726
[TBL] [Abstract][Full Text] [Related]
46. Long non-coding RNA HOTAIR/microRNA-206 sponge regulates STC2 and further influences cell biological functions in head and neck squamous cell carcinoma.
Li T; Qin Y; Zhen Z; Shen H; Cong T; Schiferle E; Xiao S
Cell Prolif; 2019 Sep; 52(5):e12651. PubMed ID: 31297902
[TBL] [Abstract][Full Text] [Related]
47. FosL1 Regulates Regional Metastasis of Head and Neck Squamous Cell Carcinoma by Promoting Cell Migration, Invasion, and Proliferation.
Hyakusoku H; Sawakuma K; Sano D; Takahashi H; Hatano T; Sato K; Isono Y; Shimada S; Takada K; Kuwahara T; Aizawa Y; Oridate N
Anticancer Res; 2021 Jul; 41(7):3317-3326. PubMed ID: 34230127
[TBL] [Abstract][Full Text] [Related]
48. FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.
Zhang X; Wu J; Luo S; Lechler T; Zhang JY
Oncotarget; 2016 Jun; 7(23):34371-83. PubMed ID: 27144339
[TBL] [Abstract][Full Text] [Related]
49. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
[TBL] [Abstract][Full Text] [Related]
50. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
[TBL] [Abstract][Full Text] [Related]
51. Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR‑26a‑5p.
Hu W; Zhao Y; Su L; Wu Z; Jiang W; Jiang X; Liu M
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34435652
[TBL] [Abstract][Full Text] [Related]
52. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
[TBL] [Abstract][Full Text] [Related]
53. miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
Huang Q; Shen YJ; Hsueh CY; Guo Y; Zhang YF; Li JY; Zhou L
BMC Cancer; 2021 Oct; 21(1):1074. PubMed ID: 34598688
[TBL] [Abstract][Full Text] [Related]
54. CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial-mesenchymal transition via inhibiting MDM2.
Wang X; Li Y; Pan M; Lu T; Wang M; Wang Z; Liu C; Hu G
Clin Sci (Lond); 2022 Nov; 136(22):1691-1710. PubMed ID: 36377775
[TBL] [Abstract][Full Text] [Related]
55. Pescadillo ribosomal biogenesis factor 1 reduction suppresses tumour growth and renders chemosensitivity of head and neck squamous cell carcinoma.
Li D; Yao C; Ding Z; Liu P; Chen X; Liu W; Yi F; Jiang C; Li H; Liu Y; Wu J
Cancer Med; 2023 Mar; 12(5):5703-5717. PubMed ID: 36217758
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
[TBL] [Abstract][Full Text] [Related]
57. The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma.
Li J; Chen W; Luo L; Liao L; Deng X; Wang Y
Aging (Albany NY); 2020 Nov; 13(1):769-781. PubMed ID: 33257597
[TBL] [Abstract][Full Text] [Related]
58. HSP90AA1 promotes lymphatic metastasis of hypopharyngeal squamous cell carcinoma by regulating epithelial-mesenchymal transition.
Tang F; Li Y; Pan M; Wang Z; Lu T; Liu C; Zhou X; Hu G
Oncol Res; 2023; 31(5):787-803. PubMed ID: 37547757
[TBL] [Abstract][Full Text] [Related]
59. IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway.
Liu P; Kong X; Yi S; Chen Y; Luo W
World J Surg Oncol; 2024 Jan; 22(1):34. PubMed ID: 38273364
[TBL] [Abstract][Full Text] [Related]
60. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
